Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 7/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | FBP1 | P09467 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9361015 | 1.00 | EP300 (0.55) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL1602959 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL423102 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL154904 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL7568098 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL1274680 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL973729 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL3149613 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL29047 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 | |
| SCHEMBL142755 | 0.98 | EP300 (0.58) | EP300PPARGPPARATRPA1FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104704-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | FUNDACIÓ INSTITUT DE INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL (ES) | 2026-05-21 | — | — | WO | claimed |
| EP-4744687-A1 | A COMBINATION, MEDICAL KIT AND MEDICAL DEVICE FOR TREATING AND/OR PREVENTING TISSUE LEAKAGE | Aesculap AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-3579890-B1 | METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES | FEMASYS INC (US) | 2025-06-18 | — | — | EP | claimed |
| US-20220025552-A1 | METHOD OF PRODUCING POLY(ALKYL CYANOACRYLATE) BASED NANO/MICROFIBERS AND USES THEREOF | CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN (DE) | 2022-01-27 | — | — | US | claimed |
| EP-3941989-A1 | CYANOACRYLATE ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2022-01-26 | — | — | EP | claimed |
| US-20220002590-A1 | Cyanoacrylate Adhesive Composition | HENKEL AG & CO KGAA (DE) | 2022-01-06 | — | — | US | claimed |
| EP-3894617-A1 | METHOD OF PRODUCING POLY(ALKYL CYANOACRYLATE) BASED NANO/MICROFIBERS AND USES THEREOF | Charité - Universitätsmedizin Berlin (DE) | 2021-10-20 | — | — | EP | claimed |
| WO-2020191510-A1 | CYANOACRYLATE ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2020-10-01 | — | — | WO | claimed |
| EP-3666940-A1 | METHOD OF PRODUCING POLY(ALKYL CYANOACRYLATE) BASED NANO/MICROFIBERS AND USES THEREOF | Charité - Universitätsmedizin Berlin (DE) | 2020-06-17 | — | — | EP | claimed |
| US-9752049-B2 | Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same | UT-BATTELLE, LLC (US) | 2017-09-05 | — | — | US | claimed |
| EP-2511355-B1 | Cyanoacrylate adhesive with improved water resistance | HENKEL IRELAND LTD (DE) | 2013-10-23 | — | — | EP | claimed |
| EP-1100380-B1 | BIOABSORBABLE BLENDS AND SURGICAL ARTICLES THEREFROM | TYCO HEALTHCARE (US) | 2011-11-02 | — | — | EP | claimed |
| EP-1360257-B1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE R & D LTD (IE) | 2007-07-25 | — | — | EP | claimed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | claimed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | claimed |
| EP-1360257-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | Loctite (R & D) Limited (IE) | 2003-11-12 | — | — | EP | claimed |
| WO-2003015743-A1 | IMMUNISATION BY MEANS OF THE LOCAL IMPLANTATION OF ANTIGENS WHICH ARE IRREVERSIBLY FIXED TO A BIOADHERENT | BOUAZIZ ADAM (FR) | 2003-02-27 | — | — | WO | claimed |
| WO-2002053666-A1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE (R & D) LIMITED (IE) | 2002-07-11 | — | — | WO | claimed |
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | S.N. BIOTECH, INC. | 2002-05-30 | — | — | US | claimed |
| US-3940362-A | Cross-linked cyanoacrylate adhesive compositions | JOHNSON & JOHNSON (US) | 1976-02-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065314-A1 | COMPOSITIONS AND METHOD FOR STIMULATING HAIR GROWTH | AREG, NGF, HDGF | EP300 488/4885PPARG 382/4885PPARA 552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.